Brief profile of the company:
TriMar Strategies GmbH is a consulting firm specialized in MedTech, Life Sciences, and Health Policy, providing evidence-based insights and strategies that help organizations innovate, compete, and adapt in dynamic markets.
On the MedTech side, we focus on product-lifecycle adjacent work: from ideation and concept testing through market feasibility, access, pricing sensitivity, competitive positioning, marketing message testing, go-to-market strategies, and post-launch management. Our team combines deep industry knowledge with robust primary and secondary market research conducted globally, helping manufacturers and SMEs make confident, data-driven decisions.
In Health Policy, we support public and private stakeholders through strategic research, engagement, and communication. Our work translates complex data into actionable insights, facilitates consensus across diverse partners, and designs initiatives that drive measurable outcomes in global and national health.
TriMar Strategies operates internationally from hubs in Europe and the USA, serving leading MedTech companies, SMEs and startups, investors, multilateral organizations, and government partners
We work with early-stage MedTech and Life Sciences innovators to help them validate market opportunities, refine product positioning, and communicate value to investors and partners. Our data-driven approach helps young companies bridge scientific innovation with commercial success.
Field of activity:
We help MedTech, Life Sciences, and biotech innovators, from startups to global leaders, translate ideas into investor-ready and market-ready strategies, grounded in data and evidence.
Products / services:
- Product concept and market feasibility testing
- Pricing and market access strategy
- Competitive positioning and message testing
- Go-to-market and commercialization strategy
- Post-launch lifecycle support
- Health policy research and stakeholder engagement
Special features:
- Dual expertise in MedTech and Health Policy
- Integration of research and strategy in one team
- Global reach with local insight
- Senior-led, high-impact consulting model
- Evidence-based, actionable results tailored to clients’ goals
- Proven ability to convene cross-sector stakeholders, evidenced by leadership in initiatives such as the Lung Cancer Consensus Statement (Read more: https://trimarstrategies.com/health-policy-strategies/)
Memberships in networks / associations:
biosaxony e.V.
We are looking for:
MedTech and Life Sciences MNCs, SMEs, and innovation-driven organizations seeking actionable research and strategy support,.
We partner with high-potential Life Sciences / biotech / MedTech start-ups and SMEs seeking clarity on market fit, pricing, access and launch readiness. We’re also open to advising early-stage ventures that want to test market assumptions or prepare for investor discussions.
We are interested in collaborating with partners on data, regulatory, or technology-focused projects.
Available for talks, roundtables, and collaborative workshops on MedTech and Health Policy topics.
Also searching for potential partners or clients interested in data-driven insights or proprietary datasets supporting market mapping in IVD.
We offer:
| WHAT | CONDITIONS |
|
|
|
|
|
|
Contact details of the company:
Headquarters:
TriMar Strategies GmbH
Schnorrstrasse 23
04229 Leipzig
Social Media: LinkedIn